The Val290Met and Pro467Leu polymorphisms are the best-characterized dominant-negative mutations of PPARγ2 and have been shown to dramatically reduce the transcriptional activity of PPARγ2 in vitro, resulting in severe IR with increasing fat accumulation, hypertension, and reduced adiponectin levels [165]. Here, PPARG is linked to Hypertension.